Assessment and treatment of the burden of migraine: A case series

Juline Bryson, Dawn C. Buse, Richard B. Lipton

Research output: Contribution to journalArticle

Abstract

Background: Migraine can take a significant toll on many aspects of sufferers' lives, including occupational, academic, social, and personal functioning. Individuals with migraine experience substantial pain and disability during migraine headaches (the ictal period), and many experience functional impairment and emotional consequences between attacks (the interictal period). The majority of migraine sufferers spend most of their lives in this interictal period; therefore, it is of great importance. Assessment tools: Treatment planning must take into account both the ictal and interictal burden. Several tools have been developed to measure the burden of migraine and to assist health care professionals in making management decisions. The Migraine Disability Assessment Scale focuses exclusively on ictal burden. The Migraine Interictal Burden Scale complements the Migraine Disability Assessment Scale by measuring interictal burden. The Migraine Prevention Questionnaire was developed based on clinical guidelines to identify patients who are appropriate candidates for preventive pharmacotherapy for migraine. Case studies: This article presents 4 cases selected to exemplify the ictal and interictal burden of migraine and the benefits of effective treatment. For each patient, individualized treatment strategies were developed using acute and preventive pharmacotherapy, as well as biobehavioral treatments. Conclusions: Migraine preventive medication and/or biobehavioral intervention may substantially improve patient health-related quality of life by reducing the frequency of migraines and the emotional and lifestyle burden produced by interictal anxiety.

Original languageEnglish (US)
Pages (from-to)254-261
Number of pages8
JournalNeurologist
Volume16
Issue number4
DOIs
StatePublished - 2010

Fingerprint

Migraine Disorders
Therapeutics
Stroke
Drug Therapy
Life Style
Decision Making
Anxiety
Quality of Life
Guidelines
Delivery of Health Care

Keywords

  • ictal/interictal burden
  • MIBS
  • migraine
  • MQP-5
  • quality of life

ASJC Scopus subject areas

  • Clinical Neurology
  • Medicine(all)

Cite this

Assessment and treatment of the burden of migraine : A case series. / Bryson, Juline; Buse, Dawn C.; Lipton, Richard B.

In: Neurologist, Vol. 16, No. 4, 2010, p. 254-261.

Research output: Contribution to journalArticle

Bryson, Juline ; Buse, Dawn C. ; Lipton, Richard B. / Assessment and treatment of the burden of migraine : A case series. In: Neurologist. 2010 ; Vol. 16, No. 4. pp. 254-261.
@article{501c8adab8884c668ae663c819fc3543,
title = "Assessment and treatment of the burden of migraine: A case series",
abstract = "Background: Migraine can take a significant toll on many aspects of sufferers' lives, including occupational, academic, social, and personal functioning. Individuals with migraine experience substantial pain and disability during migraine headaches (the ictal period), and many experience functional impairment and emotional consequences between attacks (the interictal period). The majority of migraine sufferers spend most of their lives in this interictal period; therefore, it is of great importance. Assessment tools: Treatment planning must take into account both the ictal and interictal burden. Several tools have been developed to measure the burden of migraine and to assist health care professionals in making management decisions. The Migraine Disability Assessment Scale focuses exclusively on ictal burden. The Migraine Interictal Burden Scale complements the Migraine Disability Assessment Scale by measuring interictal burden. The Migraine Prevention Questionnaire was developed based on clinical guidelines to identify patients who are appropriate candidates for preventive pharmacotherapy for migraine. Case studies: This article presents 4 cases selected to exemplify the ictal and interictal burden of migraine and the benefits of effective treatment. For each patient, individualized treatment strategies were developed using acute and preventive pharmacotherapy, as well as biobehavioral treatments. Conclusions: Migraine preventive medication and/or biobehavioral intervention may substantially improve patient health-related quality of life by reducing the frequency of migraines and the emotional and lifestyle burden produced by interictal anxiety.",
keywords = "ictal/interictal burden, MIBS, migraine, MQP-5, quality of life",
author = "Juline Bryson and Buse, {Dawn C.} and Lipton, {Richard B.}",
year = "2010",
doi = "10.1097/NRL.0b013e3181a74c17",
language = "English (US)",
volume = "16",
pages = "254--261",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Assessment and treatment of the burden of migraine

T2 - A case series

AU - Bryson, Juline

AU - Buse, Dawn C.

AU - Lipton, Richard B.

PY - 2010

Y1 - 2010

N2 - Background: Migraine can take a significant toll on many aspects of sufferers' lives, including occupational, academic, social, and personal functioning. Individuals with migraine experience substantial pain and disability during migraine headaches (the ictal period), and many experience functional impairment and emotional consequences between attacks (the interictal period). The majority of migraine sufferers spend most of their lives in this interictal period; therefore, it is of great importance. Assessment tools: Treatment planning must take into account both the ictal and interictal burden. Several tools have been developed to measure the burden of migraine and to assist health care professionals in making management decisions. The Migraine Disability Assessment Scale focuses exclusively on ictal burden. The Migraine Interictal Burden Scale complements the Migraine Disability Assessment Scale by measuring interictal burden. The Migraine Prevention Questionnaire was developed based on clinical guidelines to identify patients who are appropriate candidates for preventive pharmacotherapy for migraine. Case studies: This article presents 4 cases selected to exemplify the ictal and interictal burden of migraine and the benefits of effective treatment. For each patient, individualized treatment strategies were developed using acute and preventive pharmacotherapy, as well as biobehavioral treatments. Conclusions: Migraine preventive medication and/or biobehavioral intervention may substantially improve patient health-related quality of life by reducing the frequency of migraines and the emotional and lifestyle burden produced by interictal anxiety.

AB - Background: Migraine can take a significant toll on many aspects of sufferers' lives, including occupational, academic, social, and personal functioning. Individuals with migraine experience substantial pain and disability during migraine headaches (the ictal period), and many experience functional impairment and emotional consequences between attacks (the interictal period). The majority of migraine sufferers spend most of their lives in this interictal period; therefore, it is of great importance. Assessment tools: Treatment planning must take into account both the ictal and interictal burden. Several tools have been developed to measure the burden of migraine and to assist health care professionals in making management decisions. The Migraine Disability Assessment Scale focuses exclusively on ictal burden. The Migraine Interictal Burden Scale complements the Migraine Disability Assessment Scale by measuring interictal burden. The Migraine Prevention Questionnaire was developed based on clinical guidelines to identify patients who are appropriate candidates for preventive pharmacotherapy for migraine. Case studies: This article presents 4 cases selected to exemplify the ictal and interictal burden of migraine and the benefits of effective treatment. For each patient, individualized treatment strategies were developed using acute and preventive pharmacotherapy, as well as biobehavioral treatments. Conclusions: Migraine preventive medication and/or biobehavioral intervention may substantially improve patient health-related quality of life by reducing the frequency of migraines and the emotional and lifestyle burden produced by interictal anxiety.

KW - ictal/interictal burden

KW - MIBS

KW - migraine

KW - MQP-5

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=77954934290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954934290&partnerID=8YFLogxK

U2 - 10.1097/NRL.0b013e3181a74c17

DO - 10.1097/NRL.0b013e3181a74c17

M3 - Article

C2 - 20592569

AN - SCOPUS:77954934290

VL - 16

SP - 254

EP - 261

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 4

ER -